BusinessInnovators From 17 Countries Vie for $250,000 in Cash and In-Kind Support to Advance Diabetes Care in the 2018 Diabetes Innovation ChallengeBy Nasdaq OMXMar 20, 2018, 12:15 PM UTC
BusinessHelmsley Charitable Trust Announces Funding Opportunity to Advance Disruptive Technologies for Type 1 DiabetesBy Nasdaq OMXJan 16, 2018, 9:45 PM UTC
BusinessPatient Entrepreneur Amin Zayani of Med Angel BV Selected as the Winner of the 2017 Lyfebulb-Novo Nordisk Innovation AwardBy Nasdaq OMXNov 8, 2017, 2:14 PM UTC
BusinessHelmsley Charitable Trust Awards $52 Million to Support the Global Platform for the Prevention of Autoimmune DiabetesBy Nasdaq OMXNov 6, 2017, 2:00 PM UTC
BusinessPatient Entrepreneur Finalists Announced for the 2017 Lyfebulb-Novo Nordisk Innovation Summit and AwardBy Nasdaq OMXOct 10, 2017, 1:11 PM UTC
